| Tag | Content |
|---|
EnhancerAtlas ID | HS106-01513 |
Organism | Homo sapiens |
Tissue/cell | iPSC |
Coordinate | chr3:16728370-16729500 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| SNAI2 | MA0745.2 | chr3:16728506-16728516 | TGCACCTGTT | - | 6.02 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_32712 | chr3:16727741-16728722 | H1 | | SE_32712 | chr3:16729014-16729786 | H1 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH03I016686 | chr3 | 16728058 | 16730528 |
|
Enhancer Sequence | TTTGCTCACT GCAGTTGGAG ATTACAGAGG CACATTCTCA CAGCCACTGC AGCTAACAAG 60
CACATTTCTC AAATTAGCAT TTTTAGTGTG ATATCTGGCT TTTCCTTTCA GACTCCTGAA 120
ATTACAAATA ACTAGTTGCA CCTGTTTTCC AAATTTACCA CTTCTGCTCT CAGAATATAG 180
ATCAGAAAGT TTCATGTCTG TCTTTGAAAA TTTTATTATT GCTAAAATCT AAGATGACTC 240
AATAGCGTCA TTTGGAGTTG ACCTGATCAG ACCAGGACAC ACCATCCCCA AAATATAACT 300
GTAGAAGACC AGAATCTGCC ACCCCAAATA TCCCTCTTTT GCATAAGGAT TTTTTTGAGT 360
TGGTTATTTT GAGAAACTGC AGACAAAGGA GTTCTGAAAA GTTACCCTTT TGTAGGAGAA 420
ATTTGCATCT ATATCCATTT GTAAGGGTGT CTCCCTGTCT GCACCAGGGA TGAGAAGGAT 480
AACTAAACTA CTAGAGACTC TATAATCAAT GGAGAAGGCA TCCATTAAAT CTGCATAACA 540
AATCTGACCT GTTTTAGTGT TTTTCATGGT TATTACATCT TAATGGAAAC TCTCCCCACA 600
CCCTTCTTTC TTTGTTTCAG AGAATAATGG GATTTAAGCC TGAATTCTAA GACTACCCTT 660
TTGAGATCTA CTCTAGAGAT GTACTCATTG ATCTTGTTTT CTCCTTTGTA TACAAGAGGT 720
ACACATTATT AAACTTTTGT TTGCTTTTCT CTTGTTAATC TGTCTTTTGT TAAATGGAGT 780
TCCAGCTAAG AACTCATGAA GGGCAGAAGA GAAAATTATT TTCCCCCTCC TACAGACCCT 840
TTAAAAAGTT CTACAGACAT CCAATAATGT GTGATCCACA AAAGACACTT AGCTTCATGT 900
GGATTTTCAA GACATTTGTC ATTTAAATAA AGCTTGACTT TCACATTCAC ACCAAATTCT 960
ACAGTGTAGA ACCTTATTTT TAAAGACATT AGCTCTTATT CTTAAAGATT TAAGGAATCT 1020
TTATTTTTAT GATACTAAAA AAATCTTACT TTTTATAATA TTGCACATAA ATGTAAAGTG 1080
TTAAAAGTCT GGAAGAATAT ATAACAACTC ATCAACAATG AATACCTCTG 1130
|
